Evaluation of the clinical application of information-motivation-behavior model care combined with labetalol pharmacotherapy for patients with hypertensive disorders of pregnancy: a randomized controlled study for improving pregnancy outcomes

The IMB care model combined with labetalol medication had a positive impact on blood pressure control and pregnancy outcomes in patients with HDP, providing data support and theoretical basis for the application of this care model in HDP. However, the study also pointed out its limitations, such as single-centre design and limited sample size, and more comprehensive studies are needed to further validate these findings in the future.